Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Top diabetes tech stories from the first half of 2026

    7. Juli 2026

    Insulet launches Omnipod 5 in Spain

    7. Juli 2026

    AdaptHealth discloses patient data was stolen in cyberattack

    7. Juli 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Medtronic gets FDA nod for updated pulse oximetry system
    News

    Medtronic gets FDA nod for updated pulse oximetry system

    HealthradarBy Healthradar10. Juni 2026Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Medtronic gets FDA nod for updated pulse oximetry system
    Share
    Facebook Twitter LinkedIn Pinterest Email


    This audio is auto-generated. Please let us know if you have feedback.

    Dive Brief:

    • Medtronic has received Food and Drug Administration clearance for an updated version of its Nellcor pulse oximetry system.
    • The 510(k) clearance, which Medtronic disclosed Monday, covers a device with a new processor designed to support more consistent and reliable results across diverse skin tones. 
    • Concerns about the accuracy of pulse oximeters in people with darker skin pigmentation led the FDA to publish draft guidance on the devices last year.

    Dive Insight:

    In January, Medtronic published the results of a verification study of its new processor. Used across the full range of skin tones, the technology, Nell-EQ, achieved better oxygen saturation accuracy than the bar set in the FDA’s draft guidance. The FDA granted its Safer Technologies Program designation to the device last year, reflecting the potential for the technology to improve on the safety of existing products. 

    Nell-EQ incorporates patient- and sensor-specific signal characteristics to more consistently and reliably translate optical signals into blood oxygen results, Medtronic said. The company designed the processor to support accuracy across diverse patient populations, skin tones and clinical care settings.

    Receiving FDA clearance for Nellcor with Nell-EQ could help Medtronic as it competes with Masimo for the pulse oximetry market. Masimo, which reported revenue of $1.5 billion last year, has said Medtronic holds “a substantial share” of the market. Danaher agreed to buy Masimo for $9.9 billion in February. 

    Medtronic reported mid-teens growth in Nellcor sales in its most recent quarterly results earlier this month. Partnerships form part of the Nellcor business, with Medtronic recently extending agreements to integrate the technology into patient monitoring products sold by GE HealthCare and Mindray. 

    Medtronic plans to make Nellcor with Nell-EQ available globally in the coming months, offering clinician education and training resources to support the rollout. The skin tone issues identified by the FDA are a global concern, which the International Organization for Standardization addressed recently in a revised standard on pulse oximeters.



    Source link

    FDA Medtronic nod oximetry Pulse system updated
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleBlue Cross MA Inks Its First Oncology Value-Based Deal with Thyme Care –
    Next Article Stepful Secures $55M to Expand AI-Powered Healthcare Workforce Training
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Top diabetes tech stories from the first half of 2026

    7. Juli 2026
    News

    Insulet launches Omnipod 5 in Spain

    7. Juli 2026
    News

    AdaptHealth discloses patient data was stolen in cyberattack

    7. Juli 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025430 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025379 Views

    Luna ring review | TechRadar

    26. Dezember 2025153 Views

    Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B

    20. Februar 2026151 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025430 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025379 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.